S
Saeed Tarabichi
Researcher at Rutgers University
Publications - 4
Citations - 155
Saeed Tarabichi is an academic researcher from Rutgers University. The author has contributed to research in topics: Cancer & Downregulation and upregulation. The author has an hindex of 3, co-authored 4 publications receiving 72 citations.
Papers
More filters
Journal ArticleDOI
Intratumoral injection of the seasonal flu shot converts immunologically cold tumors to hot and serves as an immunotherapy for cancer
Jenna H. Newman,C. Brent Chesson,Nora L. Herzog,Praveen K. Bommareddy,Salvatore M. Aspromonte,Russell J. Pepe,Ricardo Estupinian,Ricardo Estupinian,Mones M. Aboelatta,Mones M. Aboelatta,Stuti Buddhadev,Saeed Tarabichi,Michael J. Lee,Shengguo Li,Daniel J. Medina,Eileena F. Giurini,Kajal Gupta,Gabriel Guevara-Aleman,Marco Rossi,Christina Nowicki,Abdulkareem Abed,Josef W. Goldufsky,Joseph R. Broucek,Joseph R. Broucek,Raquel E. Redondo,Raquel E. Redondo,David Rotter,Sachin R. Jhawar,Sachin R. Jhawar,Shang Jui Wang,Frederick J. Kohlhapp,Howard L. Kaufman,Paul G. Thomas,Paul G. Thomas,Vineet Gupta,Timothy M. Kuzel,Jochen Reiser,Joyce Paras,Michael P. Kane,Eric A. Singer,Jyoti Malhotra,Lisa K. Denzin,Derek B. Sant'Angelo,Arnold B. Rabson,Leonard Y. Lee,Ahmed Lasfar,John Langenfeld,Jason M. Schenkel,Jason M. Schenkel,Mary J. Fidler,Emily S. Ruiz,Emily S. Ruiz,Amanda L. Marzo,Jai S. Rudra,Ann W. Silk,Andrew Zloza,Andrew Zloza +56 more
TL;DR: It is reported that unadjuvanted seasonal influenza vaccination via intratumoral, but not intramuscular, injection converts “cold” tumors to hot, generates systemic CD8+ T cell-mediated antitumor immunity, and sensitizes resistant tumors to checkpoint blockade, and proposes that antipathogen vaccines may be utilized for both infection prevention and repurposing as a cancer immunotherapy.
Journal ArticleDOI
The role of the axillary Impella 5.0 device on patients with acute cardiogenic shock.
TL;DR: The Axillary Impella device allows for a minimally invasively placed device that is durable with a mean duration of 3 weeks and provides time for decision making for explant, additional therapy with either long-term devices or orthotopic heart transplant.
Journal ArticleDOI
Novel bone morphogenetic protein receptor inhibitor JL5 suppresses tumor cell survival signaling and induces regression of human lung cancer.
Jenna H. Newman,David Augeri,Rachel NeMoyer,Jyoti Malhotra,Elaine Langenfeld,Charles B. Chesson,Natalie S. Dobias,Michael J. Lee,Saeed Tarabichi,Sachin R. Jhawar,Praveen K. Bommareddy,Sh’Rae Marshall,Evita Sadimin,John E. Kerrigan,Michael Goedken,Christine Minerowicz,Salma K. Jabbour,Shengguo Li,Mary O. Carayannopolous,Andrew Zloza,John Langenfeld +20 more
TL;DR: The identified the site of metabolic instability of DMH2 and designed a novel BMP receptor inhibitor, JL5, which has a greater volume of distribution and suppresses the expression of Id1 and pTak1 in tumor xenografts and shows that the BMP signaling pathway is targetable in vivo.
Journal ArticleDOI
Competition as a Means for Improving Academic Scores and Attendance at Education Conference.
TL;DR: A competition-based model of learning was implemented at Robert Wood Johnson Medical School, an academic surgical residency program to increase the overall resident attendance to weekly education conference as well as performance on in-service examination.